Edwards Lifesciences (EW) Acquisitions (2011 - 2019)

Edwards Lifesciences has reported Acquisitions for 7 years, with the latest figure at $65.2 million in Q2 2019.

• On a quarterly basis, Acquisitions rose 3722.22% year-over-year to $65.2 million in Q2 2019; TTM through Sep 2020 was $65.2 million, a 34.93% decrease from a year earlier, with the FY2019 full-year figure at $100.2 million, changed N/A from the prior year.
• Acquisitions was $65.2 million for Q2 2019 at Edwards Lifesciences, up from $35.0 million in the prior quarter.
• The five-year high for Acquisitions was $108.0 million in Q4 2017, with the low at -$1.8 million in Q2 2018.
• Average Acquisitions over 5 years is $31.2 million, with a median of $9.5 million recorded in 2015.
• The sharpest annual moves came in 2018 and 2019: Acquisitions slumped 164.29% in 2018, then soared 3722.22% in 2019.
• Over 5 years, Acquisitions stood at $11.5 million in 2015, then sank by 33.91% to $7.6 million in 2016, then soared by 1321.05% to $108.0 million in 2017, then slumped by 101.67% to -$1.8 million in 2018, then jumped by 3722.22% to $65.2 million in 2019.
• The last three Acquisitions figures came in at $65.2 million (Q2 2019), $35.0 million (Q1 2019), and -$1.8 million (Q2 2018), per Business Quant data.